UTA bioengineering professor successfully patents new cancer trap


"Our cancer trap works just like a roach motel, where you put in some bait and the roach goes there and dies," said Liping Tang, UTA bioengineering professor and leader of the research. "We are putting biological agents in a cancer trap to attract and kill cancer cells.

"This method is effective for both diagnosing and treating metastasis cancer and can be used in combination with traditional chemotherapy and radiation therapy," he added.





"We are hoping to move toward clinical trials in the next few years as this technology could potentially significantly increase the lifespan of cancer patients," Tang said.


With more than $4 million in research expenditures in 2017, UTA's program for cancer encompasses basic cancer research, identification and diagnostics, as well as in noninvasive, midterm, invasive and postoperative therapies. UTA's multidisciplinary research teams harness proficiencies from across science, engineering, computer science, nursing and kinesiology to tackle the challenges of precision oncology and cancer treatment.

Tang's expertise encompasses a broad area, including stem cells, tissue engineering, nanotechnology, biocompatibility, biomaterials, inflammation, infection and fibrosis. He has published many of his work in high impact journals, including Biomaterials, Journal of Clinical Investigation, Proceedings of the National Academy of Sciences, Blood, Journal of Experimental Medicine, and Tissue Engineering.

"Tang is a remarkable innovator and internationally recognized researcher," said Michael Cho, UTA's chair of bioengineering. "His work is a clear example of UTA's strategic focus on health and the human condition and of the strength of multidisciplinary work."


You might also like... ×